China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country. Experts say this could slow down American innovation in the biotech space. China's ...

The authors and signatories are CEOs and board chairs of biomedical/health sciences companies. As leaders of United States companies positioned in the biomedical/health sciences landscape, we are well ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Congress is poised to ...

The biotechnology industry achieved many firsts this past year, from the first approved drug that can slow the rates of cognitive and functional decline in adults with Alzheimer’s disease, to the ...

Unless the U.S. acts rapidly now, China will almost inevitably become the world’s biotechnology superpower. The consequences for the world could be insurmountable. That’s the conclusion of a report, ...

Biotechnology Regulatory Fellowships are six-month, full-time, hands-on professional development fellowships structured to engage early career professionals in developing the evidence basis needed to ...